THE AUTEM THERAPEUTICS TEAM

We are data-driven, patient-focused game changers with a mission to improve the way we fight cancer.

Michael Choukas
Co-founder and Chief Executive Officer (CEO)
USA

Experienced Chief Executive with global strategy, operations, clinical development, clinical trials and real-world data (RWD) analytics experience at ConcertAI, Vector Oncology, UBC, SCIREX and Bain & Company. B.A. Dartmouth; M.B.A. Harvard.
Frederico Costa, MD
Founder and Chief Scientific Officer (CSO)
Brazil

Medical oncologist, co-founder and on the faculty of the Centro de Oncologia of Hospital Sírio Libanês. He is a former Medical Oncology/Hematology Fellow at Memorial Sloan-Kettering Cancer Center in New York, USA.

Bertram Wiedenmann, MD PhD
Chief Medical Officer (CMO)
Germany

Professor, Department of Internal Medicine, Division of Hepatology and Gastroenterology, Charité, University of Berlin. Chair, American Society of Clinical Oncology (ASCO) GI Cancer Symposium 2017, San Francisco, CA.


Lucas Batista Gabriel
VP, Engineering and R&D
Brazil

Data Science and AI professional previously with Let’s Code and LG Electronics. Holds a degree in Computer Engineering from Escola Politécnica University of São Paulo.



Ronald Bracken
VP, Regulatory Affairs and Quality Assurance
USA

Accomplished Regulatory, Research and Development Executive with 24 years experience in corporate R&D and manufacturing environments in numerous medical fields.

Angela Cushman
VP, Quality Assurance
USA

Over 20 years of global medical device quality and regulatory leadership experience. Previously as Senior VP of Global Quality at Avanos Medical, C.R. Bard and Kimberly Clark. Angela holds a B,S, in Chemical Engineering and M.S. in Marketing.
Chris Codeanne
Sr. Financial Advisor
USA

Seasoned executive across multiple venture, private equity backed and public companies with a proven track record of creating value and raising capital in support of rapid growth at companies such as ConcertAI and Premier Research. B.S., C.P.A., & M.B.A.
Cornelia Durand-Mura
VP, Commercial Operations
Brazil

Experienced leader in the development and launch of innovative oncology products at Merck-Serono and Baxter. B.S. in Biomedicine studies and M.B.A in Marketing from Fundação Getulio Vargas, Brazil.

Amy Howard
VP, Marketing
USA

Marketing Operations leader with oncology launch and marketing experience at Biogen and Genentech. B.S. Union College; M.B.A. Boston College.



Thomas Kelly
Product Development
USA

Medical products executive with 30 years experience in management, R&D, marketing, QA/RA and manufacturing for medical devices and pharmaceuticals at Baxter, BD, Nikkiso & Dow.
Alan Machado Coelho
Software Engineer
Brazil

Software Engineer. Electrical Engineer with Emphasis on Automation and Control from University of São Paulo, Brazil.



Rachel A. Newsome, BSN
VP, Clinical Operations
USA

Oncology nurse, certified clinical research professional, and real-world data curation expert. Previously VP of clinical patient insights at ConcertAI. Holds a BSN and is a SOCRA Certified Clinical Research Professional.
Andrew Powell
VP, Business Development and Legal Affairs
USA

Executive with track record generating global value through IP creation, M&A, commercialization, process development and corporate governance at ImClone, InterMune and Medivation. J.D. Stanford.


Pedro Strabelli
Senior Software Engineer
Brazil

Senior Software Engineer. Computer Engineer and Computer Science from University of São Paulo, Brazil.






Edward Stepanski, PhD
Senior Research Advisor
USA

Managed operations in an oncology clinical trials network, and built an oncology-focused full service CRO directing all aspects of trial activity for over 10 years. Most recently built real world datasets in oncology for regulatory submissions and other life sciences use cases for a major RWD company.
Kirk Tanner
Sr. VP, Clinical Development
USA

Oncology R&D specialist with 25+ years of industry experience. Active SAB member for Pharma and Biotech. Helped create and launch a Brain Tumor Investment Fund to catalyze new treatments to brain cancer patients. Extensive experience leading cross functional matrix teams both in discovery and early development in oncology. B.S., Ph.D.
Jack Tuszynski, PhD
VP, Medical and Biophysics R&D
Canada

M.Sc., PhD and D.Sc. in Physics and Bioinformatics, Prof. and Experimental Oncology, Cross Cancer Institute, University of Alberta, Edmonton, Canada.






Tatiana Zanesco
Study Coordinator
Brazil

BS in Biomedicine. Study coordinator at Hospital Sírio Libanês. Performed the role of study coordinator of liver transplantation at Hospital das Clínicas (HC) of the University of São Paulo, Brazil.